Lee Jun Suh, Choi Hyeong Woo, Kim Ji Su, Lee Tae Yoon, Yoon Young Chul
Department of Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Cancers (Basel). 2024 Dec 6;16(23):4093. doi: 10.3390/cancers16234093.
Hepatocellular carcinoma (HCC) is the most common primary liver cancer, the incidence of which is rising globally. Despite recent advancements in immunotherapeutic and surgical treatment modalities, the prognosis for HCC remains poor. The surgical treatment strategy for HCC comprises a multimodal effort that ranges from ablative therapy and surgical resection to liver transplantation. Thanks to collective efforts from the surgical society, there have been rapid advances in resection strategies, such as 3D printing for surgical planning and minimally invasive techniques to minimize surgical trauma. This review examines recent advancements in surgical techniques, patient selection criteria, and perioperative management for HCC resection. The purpose of this review was to provide clinicians and researchers with an up-to-date perspective on the evolving role of surgical resection in HCC treatment, and to identify key areas for future investigation to improve patient outcomes.
肝细胞癌（HCC）是最常见的原发性肝癌，其全球发病率正在上升。尽管免疫治疗和手术治疗方式最近取得了进展，但HCC的预后仍然很差。HCC的手术治疗策略包括从消融治疗、手术切除到肝移植的多模式努力。由于外科学会的共同努力，切除策略取得了快速进展，如用于手术规划的3D打印和将手术创伤降至最低的微创技术。本综述探讨了HCC切除手术技术、患者选择标准和围手术期管理的最新进展。本综述的目的是为临床医生和研究人员提供关于手术切除在HCC治疗中不断演变的作用的最新观点，并确定未来研究的关键领域以改善患者预后。
